All Stories

  1. TEA e TDAH em crianças

    Article • Psico, January 2024, EDIPUCRS

    Dr Mario R Louza, MD, PhD

  2. The burden of caregivers of schizophrenia outpatients during the COVID-19 pandemic: A same-sample comparison with the pre-pandemic burden

    Article • International Journal of Social Psychiatry, February 2023, SAGE Publications

    Dr Mario R Louza, MD, PhD

  3. Effects of Socioeconomic Status in Cognition of People with Schizophrenia: Results From a Latin American Collaboration Network with 1175 Subjects – CORRIGENDUM

    Article • Psychological Medicine, May 2022, Cambridge University Press

    Dr Mario R Louza, MD, PhD

  4. Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification

    Article • Schizophrenia Research, October 2021, Elsevier

    Dr Mario R Louza, MD, PhD

  5. Burden on caregivers of schizophrenia outpatients in Brazil: Relationship to symptomatology and functioning

    Article • International Journal of Social Psychiatry, August 2021, SAGE Publications

    Dr Mario R Louza, MD, PhD

  6. Effects of socioeconomic status in cognition of people with schizophrenia: results from a Latin American collaboration network with 1175 subjects

    Article • Psychological Medicine, June 2021, Cambridge University Press

    Dr Mario R Louza, MD, PhD

  7. Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes

    Article • Journal of Child Psychology and Psychiatry, March 2021, Wiley

    Dr Mario R Louza, MD, PhD, Dr Anastasia Christakou

  8. Analysis of structural brain asymmetries in attention‐deficit/hyperactivity disorder in 39 datasets

    Article • Journal of Child Psychology and Psychiatry, March 2021, Wiley

    Dr Mario R Louza, MD, PhD

  9. Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis

    Article • Translational Psychiatry, February 2021, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  10. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    Article • JAMA Psychiatry, January 2021, American Medical Association (AMA)

    Professor of Clinical Psychiatry Adrian PREDA, Dr Mario R Louza, MD, PhD, Dr Mauricio Henriques Serpa, Dr Anastasia Christakou

  11. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups

    Article • American Journal of Psychiatry, September 2020, American Psychiatric Association

    Dr Mario R Louza, MD, PhD, Dr Anastasia Christakou

  12. <p>Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability</p>

    Article • Neuropsychiatric Disease and Treatment, September 2020, Taylor & Francis

    Dr Mario R Louza, MD, PhD

  13. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure

    Article • Human Brain Mapping, May 2020, Wiley

    Dr Mario R Louza, MD, PhD

  14. Schizophrenia in Women

    Article • January 2020, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  15. Gray Matter Volume in Elderly adults With ADHD: Associations of Symptoms and Comorbidities With Brain Structures

    Article • Journal of Attention Disorders, July 2019, SAGE Publications

    Dr Mario R Louza, MD, PhD

  16. Subcortical brain volume, regional cortical thickness and cortical surface area across attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD)

    Article • June 2019, Cold Spring Harbor Laboratory Press

    Dr Mario R Louza, MD, PhD

  17. Longitudinal Neuropsychological Assessment in Two Elderly Adults With Attention-Deficit/Hyperactivity Disorder: Case Report

    Article • Frontiers in Psychology, May 2019, Frontiers

    Dr Mario R Louza, MD, PhD

  18. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples

    Article • American Journal of Psychiatry, April 2019, American Psychiatric Association

    Dr Mario R Louza, MD, PhD, Dr Anastasia Christakou

  19. Association of ADHD with increased motor vehicle crashes

    Article • The Journal of Pediatrics, November 2017, Elsevier

    Dr Mario R Louza, MD, PhD

  20. Neurobiological support to the diagnosis of ADHD in stimulant-naïve adults: pattern recognition analyses of MRI data

    Article • Acta Psychiatrica Scandinavica, October 2017, Wiley

    Dr Mario R Louza, MD, PhD, Dr Mauricio Henriques Serpa

  21. Corrigendum to “Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence” [Drug Alcohol Depend. 160 (2016) 97–104]

    Article • Drug and Alcohol Dependence, October 2016, Elsevier

    Dr Mario R Louza, MD, PhD

  22. Psychodynamic aspects of adults with ADHD

    Article • Journal of Attention Disorders, July 2016, SAGE Publications

    Dr Mario R Louza, MD, PhD, Vanessa V Silva

  23. High IQ May “Mask” the Diagnosis of ADHD by Compensating for Deficits in Executive Functions in Treatment-Naïve Adults With ADHD

    Article • Journal of Attention Disorders, July 2016, SAGE Publications

    Dr Mario R Louza, MD, PhD, Master Carmen S Miguel, Dr Mauricio Henriques Serpa

  24. Influence of emotional stimulus valence on inhibitory control in adults with and without ADHD

    Article • Experimental Brain Research, July 2016, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  25. Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence

    Article • Drug and Alcohol Dependence, March 2016, Elsevier

    Master Carmen S Miguel, Dr Mario R Louza, MD, PhD

  26. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness

    Article • NeuroImage Clinical, February 2016, Elsevier

    Dr Mario R Louza, MD, PhD

  27. The physician’s quality of life: Relationship with ego defense mechanisms and object relations

    Article • Comprehensive Psychiatry, November 2015, Elsevier

    Dr Mario R Louza, MD, PhD

  28. Entendendo o TDAH (foco em adultos)

    Article • Publicações ABP documentos e vídeos ABP Publications documents and videos, April 2015, Associacao Brasileira de Psiquiatria

    Dr Mario R Louza, MD, PhD

  29. Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

    Article • March 2015, Taylor & Francis

    Dr Mario R Louza, MD, PhD, Master Carmen S Miguel

  30. Esquizofrenia

    Article • Publicações ABP documentos e vídeos ABP Publications documents and videos, January 2015, Associacao Brasileira de Psiquiatria

    Dr Mario R Louza, MD, PhD

  31. Distinctive types of executive dysfunction on cocaine dependence and ADHD compared to healthy controls

    Article • Drug and Alcohol Dependence, January 2015, Elsevier

    Dr Andre Malbergier, Dr Mario R Louza, MD, PhD

  32. Mindfulness Meditation Improves Mood, Quality of Life, and Attention in Adults with Attention Deficit Hyperactivity Disorder

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Mario R Louza, MD, PhD

  33. Multimodal Magnetic Resonance Imaging Study of Treatment-Naïve Adults with Attention-Deficit/Hyperactivity Disorder

    Article • PLOS One, October 2014, PLOS

    Dr Mario R Louza, MD, PhD, Dr Mauricio Henriques Serpa

  34. Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: A systematic review

    Article • European Neuropsychopharmacology, September 2014, Elsevier

    Dr Mario R Louza, MD, PhD

  35. Fractionating Executive Functions of Adults With ADHD

    Article • Journal of Attention Disorders, August 2014, SAGE Publications

    Dr Mario R Louza, MD, PhD

  36. Poster #T53 THE KUMON METHOD FOR COGNITIVE REMEDIATION OF INDIVIDUALS WITH SCHIZOPHRENIA: A RANDOMIZED PLACEBO-CONTROLLED TRIAL

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Mario R Louza, MD, PhD

  37. Poster #M4 TREATMENT OF CLOZAPINE-INDUCED HYPERSALIVATION WITH AMISULPRIDE: A SYSTEMATIC REVIEW

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Mario R Louza, MD, PhD

  38. Health-related quality of life in adults with attention-deficit and hyperactivity disorder

    Article • Medical Express, January 2014, GN1 Genesis Network

    Dr Mario R Louza, MD, PhD

  39. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

    Article • Current Medical Research and Opinion, December 2013, Informa Healthcare

    Dr Mario R Louza, MD, PhD

  40. Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia

    Article • Neuropsychiatric Disease and Treatment, January 2013, Taylor & Francis

    Dr Mario R Louza, MD, PhD

  41. Registro Electrónico de Adherencia al Tratamiento de Esquizofrenia en Latinoamérica (e-STAR): Resultados clínicos del uso de risperidona inyectable de liberación prolongada a dos años de seguimiento

    Article • Salud Mental, January 2013, Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz

    Dr Mario R Louza, MD, PhD

  42. Poster #156 NEUROPSYCHOLOGICAL PERFORMANCE OF INDIVIDUALS AT ULTRA HIGH RISK OR FIRST EPISODE PSYCHOSIS

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Mario R Louza, MD, PhD

  43. A Multicenter, Open-Label Trial to Evaluate the Quality of Life in Adults With ADHD Treated With Long-Acting Methylphenidate (OROS MPH)

    Article • Journal of Attention Disorders, February 2012, SAGE Publications

    Dr Mario R Louza, MD, PhD

  44. Is psychodynamic psychotherapy an effective intervention for individuals at ultra-high risk (UHR) of psychosis?: a case report

    Article • Jornal Brasileiro de Psiquiatria, January 2012, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  45. Personal and Social Performance (PSP) scale for patients with schizophrenia: translation to Portuguese, cross-cultural adaptation and interrater reliability

    Article • Jornal Brasileiro de Psiquiatria, January 2012, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  46. Prodromal Questionnaire: translation, adaptation to Portuguese and preliminary results in ultra-high risk individuals and first episode psychosis

    Article • Jornal Brasileiro de Psiquiatria, January 2012, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  47. Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia

    Article • Neuropsychiatric Disease and Treatment, June 2011, Taylor & Francis

    Dr Mario R Louza, MD, PhD, Irismar Reis de Oliveira

  48. Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

    Article • Neuropsychiatric Disease and Treatment, December 2010, Taylor & Francis

    Dr Mario R Louza, MD, PhD

  49. Exploring the knowledge contained in neuroimages: Statistical discriminant analysis and automatic segmentation of the most significant changes

    Article • Artificial Intelligence in Medicine, June 2010, Elsevier

    Dr Mario R Louza, MD, PhD

  50. Lack of Association Between a 3’UTR VNTR Polymorphism of Dopamine Transporter Gene (SLC6A3) and ADHD in a Brazilian Sample of Adult Patients

    Article • Journal of Attention Disorders, March 2010, SAGE Publications

    Dr Mario R Louza, MD, PhD

  51. Association between a SLC6A3 intron 8 VNTR functional polymorphism and ADHD in a Brazilian sample of adult patients

    Article • Brazilian Journal of Psychiatry, December 2009, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  52. Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol

    Article • CNS Spectrums, February 2009, Cambridge University Press

    Dr Mario R Louza, MD, PhD

  53. Insight, cognitive dysfunction and symptomatology in schizophrenia

    Article • European Archives of Psychiatry and Clinical Neuroscience, April 2008, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  54. 326 – Brazilian open-label switch study in noncompliant schizophrenic patients from oral antipsychotics to long-acting risperidone: A six-month interim analysis of a 12-month, multicentric study

    Article • Schizophrenia Research, February 2008, Elsevier

    Dr Mario R Louza, MD, PhD

  55. Letter to the Editor

    Article • Journal of Attention Disorders, May 2007, SAGE Publications

    Dr Mario R Louza, MD, PhD

  56. Alterações cognitivas na esquizofrenia: conseqüências funcionais e abordagens terapêuticas

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  57. Detecção precoce: é possível prevenir a esquizofrenia?

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  58. Novos antipsicóticos para o tratamento da esquizofrenia

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  59. Questões atuais no tratamento farmacológico do TDAH em adultos com metilfenidato

    Article • Jornal Brasileiro de Psiquiatria, January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  60. Insight and regional brain volumes in schizophrenia

    Article • European Archives of Psychiatry and Clinical Neuroscience, September 2006, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  61. Attention deficit hyperactivity disorder (ADHD) in adults: social-demographic profile from a university hospital ADHD outpatient unit in São Paulo, Brazil

    Article • Arquivos de Neuro-Psiquiatria, September 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  62. Oestrogen-A Protective Factor in Schizophrenia?

    Article • Current Psychiatry Reviews, August 2006, Bentham Science Publishers

    Professor Anita Riecher-Rössler, Dr Mario R Louza, MD, PhD

  63. Fixed High-Dose Electroconvulsive Therapy in the Elderly With Depression

    Article • Journal of Ect, June 2006, Wolters Kluwer Health

    Dr Mario R Louza, MD, PhD

  64. Neuropsychiatric Symptoms in Alzheimer Disease and Cognitively Impaired, Nondemented Elderly From a Community-Based Sample in Brazil: Prevalence and Relationship With Dementia Severity

    Article • American Journal of Geriatric Psychiatry, May 2006, Elsevier

    Dr Mario R Louza, MD, PhD

  65. Painel brasileiro de especialistas sobre diagnóstico do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos

    Article • Revista de Psiquiatria do Rio Grande do Sul, April 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  66. Adaptação transcultural para o português da escala Adult Self-Report Scale para avaliação do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos

    Article • Archives of Clinical Psychiatry (São Paulo), January 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  67. International clinical practice guidelines for early psychosis

    Article • The British Journal of Psychiatry, August 2005, Royal College of Psychiatrists

    Dr Mario R Louza, MD, PhD

  68. Maintenance Treatment of Severe Tardive Dyskinesia With Clozapine

    Article • Journal of Clinical Psychopharmacology, April 2005, Wolters Kluwer Health

    Dr Mario R Louza, MD, PhD

  69. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study

    Article • Schizophrenia Research, February 2004, Elsevier

    Dr Mario R Louza, MD, PhD

  70. Schizophrenia and use of antipsychotics: Prevalence of overweight, lipid abnormalities and diabetes mellitus

    Article • Schizophrenia Research, March 2003, Elsevier

    Dr Mario R Louza, MD, PhD

  71. Willy Mayer-Gross (1889-1961)

    Article • Archives of Clinical Psychiatry (São Paulo), January 2003, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  72. Os antipsicóticos de nova geração e suas meta-análises

    Article • Archives of Clinical Psychiatry (São Paulo), January 2003, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  73. Demência com corpúsculos de Lewy: uma entidade distinta com tratamento específico?

    Article • Brazilian Journal of Psychiatry, September 2002, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  74. Volumetric MRI Measurements Can Differentiate Alzheimer’s Disease, Mild Cognitive Impairment, and Normal Aging

    Article • International Psychogeriatrics, March 2002, Elsevier

    Dr Mario R Louza, MD, PhD

  75. Do Religious Mediumship Dissociative Experiences Conform to the Sociocognitive Theory of Dissociation?

    Article • Journal of Trauma & Dissociation, January 2002, Taylor & Francis

    Dr Mario R Louza, MD, PhD

  76. Attention deficit hiperactivity disorder (ADHD) in adults: Demographic caracteristics, comorbidity and treatment

    Article • European Neuropsychopharmacology, January 2001, Elsevier

    Dr Mario R Louza, MD, PhD

  77. Papel modulador do estradiol sobre os transtornos psíquicos

    Article • Brazilian Journal of Psychiatry, December 2000, FRACTAL EDITORA LTDA

    Dr Mario R Louza, MD, PhD

  78. Relação entre data de admissão hospitalar e período do ciclo menstrual de mulheres com diagnóstico de esquizofrenia

    Article • Brazilian Journal of Psychiatry, June 2000, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  79. Manejo clínico do primeiro episódio psicótico

    Article • Brazilian Journal of Psychiatry, May 2000, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  80. Clozapine efficacy in tardive dyskinesia — 3 years' follow-up

    Article • Schizophrenia Research, January 2000, Elsevier

    Dr Mario R Louza, MD, PhD

  81. Dissociação e transtornos dissociativos: modelos teóricos

    Article • Brazilian Journal of Psychiatry, December 1999, FapUNIFESP (SciELO)

    Dr Mario R Louza, MD, PhD

  82. Clozapine efficacy in tardive dyskinesia in schizophrenic patients

    Article • European Archives of Psychiatry and Clinical Neuroscience, October 1998, Springer Science + Business Media

    Dr Mario R Louza, MD, PhD

  83. Treatment of severe Tardive Dyskinesia (TD) in refractory schizophrenics with clozapine

    Article • Schizophrenia Research, January 1997, Elsevier

    Dr Mario R Louza, MD, PhD

  84. Results of ECT for a case of depression in Wilson's disease

    Article • Journal of Neuropsychiatry, August 1995, American Psychiatric Association

    Dr Mario R Louza, MD, PhD

  85. Higher morbidity risk for schizophrenia in males: Fact or fiction?

    Article • Comprehensive Psychiatry, January 1994, Elsevier

    Professor Anita Riecher-Rössler, Dr Mario R Louza, MD, PhD

  86. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEP) IN PSYCHIATRIC INPATIENTS.

    Article • Clinical Neuropharmacology, January 1992, Wolters Kluwer Health

    Dr Mario R Louza, MD, PhD

  87. Functional relationship among brain regions in schizophrenia: evaluation with pearson's product-moment correlation between event-related potentials (ERPs)

    Article • Electroencephalography and Clinical Neurophysiology, January 1990, Elsevier

    Dr Mario R Louza, MD, PhD

  88. Normative Aspekte der somatosensorisch evozierten P300-Komponente

    Article • Klinische Neurophysiologie, June 1989, Thieme Publishing Group

    Dr Mario R Louza, MD, PhD

  89. Differences between Paranoid and Nonparanoid Schizophrenic Patients on the Somatosensory P300 Event-Related Potential

    Article • Neuropsychobiology, January 1989, Karger Publishers

    Dr Mario R Louza, MD, PhD

  90. Haloperidol Plasma Level after a Test Dose as Predictor for the Clinical Response to Treatment in Acute Schizophrenic Patients

    Article • Pharmacopsychiatry, September 1988, Thieme Publishing Group

    Dr Mario R Louza, MD, PhD

  91. A Region-Based Ontology of the Brain Ventricular System and Its Relation to Schizophrenia

    Article • IGI Global

    Dr Mario R Louza, MD, PhD